Meet the PIPAC pioneer team
Behind CapnoPharm’s innovation is a team driven by one purpose: helping patients live better by changing how peritoneal and pleural cancer are treated.
Stéphane Rohan Laurent
CCO – Chief Commercial Officer
Stéphane has 15+ years’ experience in international sales & business development in senior corporate and consulting roles in both
Europe and Asia. Most recently, and prior to joining CapnoPharm, Stéphane was CapnoMed’s Country Head – India since 2017, before taking on the role of Regional Head – Asia & Middle East in 2020. A board-certified medical affairs specialist (BCMAS), Stéphane’s dedication to promoting innovation in cancer care is driven by his strong interpersonal skills, extensive international sales and distribution experience and ability to work effectively and creatively across cultures and geographies. Stéphane holds a Master’s degree in International Business and Economic Policy from Sciences Po Paris and a Master’s in English Language, Literature & Civilization from the Sorbonne University, Paris, France.
Dr. Marc Reymond
CEO – Chief Executive Officer
Prof. Reymond, MD, is a board-certified gastrointestinal surgeon and the inventor of Pressurized IntraPeritoneal Chemotherapy (PIPAC).
He graduated as a physician from the University of Geneva, Switzerland, completed an MBA in Science & Technology with LaSalle University, PA, USA, and a postgraduate diploma in artificial intelligence with McCombs at U Austin, TX, USA. Prof. Reymond is ranked as Top-Physician nationwide in Germany. He has published over 180 peer-reviewed publications, 6 books, and 50+ book chapters. He has raised more than €28 Mio R&D funding. He is the founder of three biotechnology companies, of a non-profit biobank, and holder of nine innovation awards. He is Committee President/Member in major grant and audit agencies. He has been invited to numerous national and international postgraduate courses and lectures in leading universities worldwide.
Dr. Hans Schönfelder, PhD, is a pharmacist and pharmaceutical technologist specializing in emulsifying systems,nanoemulsions, and
PIPAC therapy. With a PhD in Pharmaceutical Technology and over five years of hands-on experience, he transforms advanced science into innovative drug delivery solutions, making cancer treatments more precise and effective. His work is driven by a passion for improving patient care and turning cutting-edge research into real-world impact.
Mandar Mehta
Mandar Mehta is Director of Quality Management and Regulatory Affairs and serves as PRRC, with nearly 10 years of experience in medical device development.
He has deep, hands-on expertise in ISO 13485–compliant quality systems and EU MDR regulatory strategy, covering the full device lifecycle from early R&D and prototyping through validation, pilot manufacturing, and market readiness.
With a background in biomedical engineering and international research experience, Mandar works at the intersection of engineering, quality, and regulatory compliance, applying a structured, pragmatic approach that enables innovation while ensuring patient safety and regulatory compliance.
Johanna Ekholm is a seasoned Regulatory Affairs and Quality Management professional with over 10 years of experience in the health technology field.
She has worked at the Finnish Medicines Agency and in medical device companies, bringing a broad perspective to regulatory strategy, quality systems, and device supervision. Johanna is a qualified Lead Auditor for ISO 13485 and has a background spanning research, healthcare, and public health. She holds Master’s and Bachelor’s degrees in Biotechnology from Tampere University of Technology, and a Bachelor’s degree in Public Health and Registered Nursing from Tampere University of Applied Sciences.
Stéphane Rohan Laurent
CCO – Chief Commercial Officer
Stéphane has 15+ years’ experience in international sales & business development in senior corporate and consulting roles in both
Europe and Asia. Most recently, and prior to joining CapnoPharm, Stéphane was CapnoMed’s Country Head – India since 2017, before taking on the role of Regional Head – Asia & Middle East in 2020. A board-certified medical affairs specialist (BCMAS), Stéphane’s dedication to promoting innovation in cancer care is driven by his strong interpersonal skills, extensive international sales and distribution experience and ability to work effectively and creatively across cultures and geographies. Stéphane holds a Master’s degree in International Business and Economic Policy from Sciences Po Paris and a Master’s in English Language, Literature & Civilization from the Sorbonne University, Paris, France.